FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059696875> ?p ?o ?g. }

• W2059696875 endingPage "4457" @default.
• W2059696875 startingPage "4446" @default.
• W2059696875 abstract "Abstract Obesity is associated with a worse breast cancer prognosis and elevated levels of inflammation, including greater cyclooxygenase-2 (COX-2) expression and activity in adipose-infiltrating macrophages. The product of this enzyme, the proinflammatory eicosanoid prostaglandin E2 (PGE2), stimulates adipose tissue aromatase expression and subsequent estrogen production, which could promote breast cancer progression. This study demonstrates that daily use of a nonsteroidal anti-inflammatory drug (NSAID), which inhibits COX-2 activity, is associated with reduced estrogen receptor α (ERα)–positive breast cancer recurrence in obese and overweight women. Retrospective review of data from ERα-positive patients with an average body mass index of &gt;30 revealed that NSAID users had a 52% lower recurrence rate and a 28-month delay in time to recurrence. To examine the mechanisms that may be mediating this effect, we conducted in vitro studies that utilized sera from obese and normal-weight patients with breast cancer. Exposure to sera from obese patients stimulated greater macrophage COX-2 expression and PGE2 production. This was correlated with enhanced preadipocyte aromatase expression following incubation in conditioned media (CM) collected from the obese-patient, sera-exposed macrophages, an effect neutralized by COX-2 inhibition with celecoxib. In addition, CM from macrophage/preadipocyte cocultures exposed to sera from obese patients stimulated greater breast cancer cell ERα activity, proliferation, and migration compared with sera from normal-weight patients, and these differences were eliminated or reduced by the addition of an aromatase inhibitor during CM generation. Prospective studies designed to examine the clinical benefit of NSAID use in obese patients with breast cancer are warranted. Cancer Res; 74(16); 4446–57. ©2014 AACR." @default.
• W2059696875 created "2016-06-24" @default.
• W2059696875 creator A5012209573 @default.
• W2059696875 creator A5012270193 @default.
• W2059696875 creator A5036400845 @default.
• W2059696875 creator A5040460076 @default.
• W2059696875 creator A5043351508 @default.
• W2059696875 creator A5048164856 @default.
• W2059696875 creator A5054763940 @default.
• W2059696875 creator A5064198971 @default.
• W2059696875 creator A5083922162 @default.
• W2059696875 date "2014-08-13" @default.
• W2059696875 modified "2023-09-27" @default.
• W2059696875 title "NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin–Aromatase Interactions" @default.
• W2059696875 cites W1519868104 @default.
• W2059696875 cites W18136163 @default.
• W2059696875 cites W1922007189 @default.
• W2059696875 cites W1969780570 @default.
• W2059696875 cites W1974196451 @default.
• W2059696875 cites W1984262137 @default.
• W2059696875 cites W1986361613 @default.
• W2059696875 cites W1995448901 @default.
• W2059696875 cites W2005581755 @default.
• W2059696875 cites W2006818027 @default.
• W2059696875 cites W2016285450 @default.
• W2059696875 cites W2017864770 @default.
• W2059696875 cites W2027186991 @default.
• W2059696875 cites W2030724182 @default.
• W2059696875 cites W2042276084 @default.
• W2059696875 cites W2046917725 @default.
• W2059696875 cites W2051135482 @default.
• W2059696875 cites W2065266563 @default.
• W2059696875 cites W2067287544 @default.
• W2059696875 cites W2067815741 @default.
• W2059696875 cites W2087710728 @default.
• W2059696875 cites W2094676957 @default.
• W2059696875 cites W2096840197 @default.
• W2059696875 cites W2099687396 @default.
• W2059696875 cites W2103921344 @default.
• W2059696875 cites W2112253531 @default.
• W2059696875 cites W2114120215 @default.
• W2059696875 cites W2115138807 @default.
• W2059696875 cites W2125381755 @default.
• W2059696875 cites W2125471714 @default.
• W2059696875 cites W2126453260 @default.
• W2059696875 cites W2131080865 @default.
• W2059696875 cites W2141662760 @default.
• W2059696875 cites W2145533373 @default.
• W2059696875 cites W2150966393 @default.
• W2059696875 cites W2151172917 @default.
• W2059696875 cites W2153216542 @default.
• W2059696875 cites W2158960911 @default.
• W2059696875 cites W2160032256 @default.
• W2059696875 cites W2165038925 @default.
• W2059696875 cites W2171087521 @default.
• W2059696875 cites W2189084434 @default.
• W2059696875 doi "https://doi.org/10.1158/0008-5472.can-13-3603" @default.
• W2059696875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25125682" @default.
• W2059696875 hasPublicationYear "2014" @default.
• W2059696875 type Work @default.
• W2059696875 sameAs 2059696875 @default.
• W2059696875 citedByCount "75" @default.
• W2059696875 countsByYear W20596968752014 @default.
• W2059696875 countsByYear W20596968752015 @default.
• W2059696875 countsByYear W20596968752016 @default.
• W2059696875 countsByYear W20596968752017 @default.
• W2059696875 countsByYear W20596968752018 @default.
• W2059696875 countsByYear W20596968752019 @default.
• W2059696875 countsByYear W20596968752020 @default.
• W2059696875 countsByYear W20596968752021 @default.
• W2059696875 countsByYear W20596968752022 @default.
• W2059696875 countsByYear W20596968752023 @default.
• W2059696875 crossrefType "journal-article" @default.
• W2059696875 hasAuthorship W2059696875A5012209573 @default.
• W2059696875 hasAuthorship W2059696875A5012270193 @default.
• W2059696875 hasAuthorship W2059696875A5036400845 @default.
• W2059696875 hasAuthorship W2059696875A5040460076 @default.
• W2059696875 hasAuthorship W2059696875A5043351508 @default.
• W2059696875 hasAuthorship W2059696875A5048164856 @default.
• W2059696875 hasAuthorship W2059696875A5054763940 @default.
• W2059696875 hasAuthorship W2059696875A5064198971 @default.
• W2059696875 hasAuthorship W2059696875A5083922162 @default.
• W2059696875 hasConcept C121608353 @default.
• W2059696875 hasConcept C126322002 @default.
• W2059696875 hasConcept C134018914 @default.
• W2059696875 hasConcept C171089720 @default.
• W2059696875 hasConcept C2776166826 @default.
• W2059696875 hasConcept C2777164284 @default.
• W2059696875 hasConcept C2777956040 @default.
• W2059696875 hasConcept C2780221984 @default.
• W2059696875 hasConcept C2780586474 @default.
• W2059696875 hasConcept C530470458 @default.
• W2059696875 hasConcept C71924100 @default.
• W2059696875 hasConceptScore W2059696875C121608353 @default.
• W2059696875 hasConceptScore W2059696875C126322002 @default.
• W2059696875 hasConceptScore W2059696875C134018914 @default.
• W2059696875 hasConceptScore W2059696875C171089720 @default.
• W2059696875 hasConceptScore W2059696875C2776166826 @default.

• next